Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver
This item is licensed under:Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Title: | Outcome of Living-Donor Liver Transplantation Using Grafts from Donors Treated for Fatty Liver |
Authors: | Fujii, Yuki Browse this author | Kawamura, Norio Browse this author →KAKEN DB | Zaitsu, Masaaki Browse this author →KAKEN DB | Watanabe, Masaaki Browse this author →KAKEN DB | Goto, Ryoichi Browse this author →KAKEN DB | Kamiyama, Toshiya Browse this author →KAKEN DB | Taketomi, Akinobu Browse this author →KAKEN DB | Shimamura, Tsuyoshi Browse this author →KAKEN DB |
Keywords: | Diet Therapy | Fatty Liver | Liver Transplantation | Living Donors |
Issue Date: | 10-Jan-2020 |
Publisher: | International Scientific Information, Inc. |
Journal Title: | Annals of transplantation |
Volume: | 25 |
Start Page: | UNSP e920677 |
Publisher DOI: | 10.12659/AOT.920677 |
Abstract: | Background: The aim of this study was to determine the efficacy of treating donors' fatty liver (FL) and to assess early graft function in recipients who received treated FL grafts in living-donor liver transplantation (LDLT). Material/Methods: Data were collected for adult-to-adult LDLTs. Donors diagnosed with FL (FL group) received diet-exercise and pharmacological treatment. The perioperative findings and early transplanted graft function were compared with those of donors without FL (non-FL group) during the same period. Results: Of 30 donors, 8 were determined to have FL The median duration of treatment for FL was 58 days. The liver-to- spleen attenuation ratios on CT scan in the FL group were significantly improved after treatment: 0.95 (0.62-1.06) to 1.2 (1.12-1.46) (P=0.003). Liver biopsy prior to donor surgery showed <= 10% fatty infiltration. Postoperative laboratory findings of the donors in the FL group were comparable to those in the non-FL group: maximum alanine transaminase (189.6 +/- 94.7 IU/L vs. 196.8 +/- 57.4) and maximum total bilirubin (2.2 +/- 1.1 mg/dl vs. 1.7 +/- 0.5 mg/dL). No major complications were observed after donor hepatectomy in either group. There were no significant differences between the 2 groups in early graft function, as evaluated by laboratory data, ascites volume, and bile production 2 weeks postoperatively. Graft and patient survival were 100% in both groups at 3 months. Conclusions: Preoperative intentional treatment for FL was effective. Early graft function and donor postoperative course were comparable in the 2 groups. These results suggest that well-treated steatotic grafts can be used without jeopardizing donor safety. |
Rights: | https://creativecommons.org/licenses/by-nc-nd/4.0/ |
Type: | article |
URI: | http://hdl.handle.net/2115/76802 |
Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
|